AMARIN CORP PLC\UK Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
AMARIN CORP PLC\UK (AMRN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 38.40 million shares for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2012-11-08
- AMARIN CORP PLC\UK antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2012-09-30 was 38.40M shares, a 1100.00% increase year-over-year.
- AMARIN CORP PLC\UK antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2012-03-31 was 51.50M shares, a 4581.82% increase year-over-year.
- AMARIN CORP PLC\UK antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2011-09-30 was 3.20M shares.
- AMARIN CORP PLC\UK antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2011-03-31 was 1.10M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|
| 2012-09-30 | 38.40M shares 10-Q · filed 2012-11-08 | 38.40M shares 10-Q · filed 2012-11-08 |
| 2012-03-31 | 51.50M shares 10-Q · filed 2012-05-08 | |
| 2011-09-30 | 3.20M shares 10-Q · filed 2012-11-08 | 31.90M shares 10-Q · filed 2012-11-08 |
| 2011-03-31 | 1.10M shares 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |